Skip to content

Characterization of health-relevant compounts of breast milk

Characterization of health-relevant compounts of breast milk

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023072
Enrollment
94
Registered
2020-10-20
Start date
2020-11-07
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigation of the content of undercarboxylated Osteocalcin and erucic acid in breast milk

Interventions

Group 1: Analysis of undercarboxylated osteocalcin and erucic acid in breast milk at 4 time points: 1. day 1-4 postpartum (pp
colostrum)
2. day 7 pp (transitory milk)
3. 4 weeks pp (mature breast milk)
4. 3 months pp (mature breast milk)

Sponsors

Forschungsdepartment Kinderernährung, Universitätsklinik für Kinder- und Jugendmedizin, St. Josef-Hospital, Ruhr-Universität Bochum
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women from the age of 18 years, who have recently given birth; Women who intend to breastfeed fully or partially for at least 3 months; Availability of a freezer (-18°C)

Exclusion criteria

Exclusion criteria: Mothers of premature babies (< 2500 g, < 37 weeks of pregnancy); Presence of type 1, type 2 or gestational diabetes mellitus; Insufficient knowledge of the German language

Design outcomes

Primary

MeasureTime frame
Prospective recording of the concentrations of ucOCN and erucic acid in breast milk at different time points in the first three month postpartum (pp) (day 1-4 pp; day 7 pp; 4 weeks pp; 3 months pp).

Secondary

MeasureTime frame
Correlation of lifestyle factors such as diet and physical activity with ucOCN and erucic acid levels in breast milk (day 1-4 postpartum (pp); day 7 pp; 4 weeks pp; 3 months pp). Other potential influencing factors such as smoking, medication intake etc. are also recorded. Investigation of ucOCN and erucic acid levels in samples of industrially manufactured infant formula.

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026